Non-VKA Oral Anticoagulant and Risk of Myocardial Infarction
| Autor: | Zi-Liang Ye, Wen-Qin Guo, Lang Li |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
business.industry MEDLINE Warfarin Atrial fibrillation 030204 cardiovascular system & hematology medicine.disease 03 medical and health sciences 0302 clinical medicine Internal medicine Oral anticoagulant medicine Cardiology cardiovascular diseases 030212 general & internal medicine Myocardial infarction Cardiology and Cardiovascular Medicine business Cohort study medicine.drug |
| Zdroj: | Journal of the American College of Cardiology. 72:2093 |
| ISSN: | 0735-1097 |
| DOI: | 10.1016/j.jacc.2018.07.091 |
| Popis: | Lee et al. [(1)][1] performed a nationwide cohort study to debate the association of a direct oral anticoagulant (DOAC) and myocardial infarction (MI) risk. They concluded that the DOAC was associated with lower MI risk than warfarin, while there was no difference between the individual DOACs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|